Kieran Pemberton, PhD, is the Senior Director of Research Development for the Children’s Mercy Research Institute. Among his roles within the CMRI, Dr. Pemberton is the liaison between the researchers at Children’s Mercy, the Research Institute leadership team, and the Research Administration team. He was the CMRI liaison between the owner, architect and construction company during the design, build and occupation of the new CMRI building. His other CMRI roles include serving as the Director of the Children’s Mercy Internal Grants Program and Director of the CM Summer Scholar Program.
Dr. Pemberton works closely with members of the Children’s Mercy philanthropy team and several of hospital donors, including Braden’s Hope for Childhood Cancer, Noah’s Bandage Project, Curing Kids Cancer and Big Slick. He is a member of the Inclusion and Diversity in Research Work Group and co-directs the Translational Research Seminar series with a colleague at the Stowers Institute for Medical Research.
Prior to joining Children’s Mercy Kansas City, Dr. Pemberton was the Administrative Director of Frontiers: The Heartland Institute for Clinical and Translational Research, the $25 Million NIH-funded Clinical and Translational Science Award at the University of Kansas Medical Center.
Originally from Derry, Northern Ireland, he graduated with a Bachelor of Science degree in cell biology and immunology from the University College of Wales, Aberystwyth, in 1987. He obtained his PhD in molecular biology from the Medical Research Council’s Clinical Sciences Centre at Imperial College London, in 1997.
Dr. Pemberton completed postdoctoral training at the National Institute for Medical Research (NIMR) in Mill Hill, London from 1997 to 2000. He joined the Stowers Institute for Medical Research in Kansas City in 2000, where he held a variety of positions including research specialist, senior laboratory manager for the Scientific Director and chair of the Institutional Animal Care and Use Committee. His research focus was on the MLL (mixed lineage leukemia) gene and the role it plays in regulating members of the Hox family of genes.
Dr. Pemberton is an experienced scientific, academic and health care administrator and brings a background in basic science and a thorough understanding of the research grant processes to his position at the CMRI, where he facilitates translational science, bringing the breakthrough results of laboratory research to the hospital’s patients and clinics.